Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14301
-
14302
-
14303
Effects of a single dose of ivermectin on viral and clinical outcomes in asymptomatic sars-cov-2 infected subjects: A pilot clinical trial in lebanon
Published 2021“…Methods: A randomized controlled trial was conducted in 100 asymptomatic Lebanese subjects that have tested positive for SARS-CoV2. …”
Get full text
Get full text
-
14304
-
14305
DataSheet1_Decreasing acid value of fatty acid ethyl ester products using complex enzymes.PDF
Published 2024“…The optimal reaction conditions were: 1% addition of liquid lipase Eversa<sup>®</sup> Transform 2.0% and 0.8% of enzyme dry powder CALB, reaction temperature 35°C, alcohol-oil ratio 9:1 (mol/mol), 0.8 g/g of 4A-MS and reaction time 24 h. Under the optimal reaction conditions, the FAEE yield was 90.8% ± 1.5% and its acid value was decreased from 12.0 ± 0.2 mgKOH/g to 0.39 ± 0.10 mgKOH/g. …”
-
14306
DataSheet_4_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip
Published 2022“…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
-
14307
DataSheet_3_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip
Published 2022“…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
-
14308
DataSheet_6_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip
Published 2022“…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
-
14309
DataSheet_1_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip
Published 2022“…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
-
14310
DataSheet_2_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip
Published 2022“…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
-
14311
DataSheet_7_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip
Published 2022“…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
-
14312
Inhibition of PKA by siRNA increased cell proliferation and decreases apoptosis in endothelial cells under high glucose treatment.
Published 2012“…<p>Cells were transfected with siRNA and then treated with 5.6 mM glucose or 25 mM glucose for 72 hours: A: siRNA enhanced cell proliferation under high glucose conditions B: siRNA decreased apoptosis under high glucose conditions. *, p<0.05 compared with 5.6 mM condition. n = 6.…”
-
14313
-
14314
-
14315
-
14316
-
14317
Knockdown of OAMB or 5-HT<sub>1A</sub> in IPCs resulted in opposite phenotypes in a capillary feeding assay (CAFE).
Published 2014“…<p><b>A</b> Diminishing 5-HT<sub>1A</sub> in IPCs (<i>Dilp2</i>-Gal4><i>5-HT<sub>1A</sub></i>-RNAi) significantly decreases food intake only during day 2. …”
-
14318
-
14319
DataSheet1_Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.DOCX
Published 2021“…</p><p>Results: Anti-IL-5 therapy was associated with a decrease in acute exacerbation rate (RR 0.89; 95% CI 0.84 to 0.95, I<sup>2</sup> = 0%) and the severe adverse events (RR 0.90; 95% CI 0.84 to 0.97, I<sup>2</sup> = 0%). …”
-
14320